Neko Health, the health tech startup co-founded by Spotify's Daniel Ek, has raised $700 million in a Series C funding round. The company plans to use the money to launch its first US clinic in New York later this year, bringing its AI-powered body scanning service to American customers.
The screening service combines medical imaging, blood tests, proprietary sensors, and a clinician review to give people a detailed picture of their health.
Who invested in Neko Health's $700 million round
The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, according to the company. Existing investors Atomico, General Catalyst, and Lakestar also participated. New backers include Liberty City Ventures, Positive Sum, and BDT & MSD.
David Ofer of O.G. Venture Partners will join Neko's board, subject to regulatory approval.
According to The Wall Street Journal, the body-scanning technology startup plans to use the funding to launch its first U.S. clinic in New York later this year.
Neko Health's total funding crosses $1 billion
The latest round brings Neko's disclosed funding since 2023 to more than $1 billion. The company raised $65 million in a Series A round in 2023 and another $260 million in January 2025.
As reported by Bloomberg, Neko Health has raised $700 million from venture capitalists, billionaires, and celebrities.
What Neko Health's body scan service offers
Neko Health's preventive screening service is designed to catch health issues early. The company's full-body scan uses AI to analyze a person's health, combining multiple diagnostic tools in one visit.
According to MobiHealthNews, Neko Health offers a full-body scan to analyze one's health and has raised a whopping $700 million in Series C funding.
The addition of body composition measures, captured in seconds during the scan, and clinician review of wearable data, is now live across all locations, according to Neko Health's press release.
Our Take: A big bet on preventive health
Neko Health's massive funding round shows that investors are betting heavily on the idea that people want to know more about their health before they get sick. The $700 million raise — on top of more than $300 million already raised — is a strong vote of confidence in AI-driven preventive medicine.
But the real test will come when Neko opens its doors in New York. The US healthcare market is crowded and expensive. Customers will need to see clear value in paying for a full-body scan when traditional checkups already exist. If Neko can prove its scans catch problems early and save people money or worry in the long run, this could be a game-changer. If not, it is a very expensive experiment.
For now, the company has the money and the backing to try. We will be watching closely.
